Ozempic maker Novo Nordisk (NVO) announced mixed results today for a phase 2 trial of an experimental weight loss pill that ...

Shares were down 4.3% at 1330 GMT, the lowest since August 8, after the company announced headline results from its trial of ...

Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish drugmaker's experimental obesity pill monlunabant came in below market expectations.

A new type of blood test using lipids could make it easier to identify children at risk of complications around obesity ...

The biggest decline was among non-Hispanic Black residents. Their cancer death rate dropped from 245.1 to 124, a 49.4% ...

Researchers have discovered that remodeling of extracellular matrix (ECM) in the hypothalamus, specifically around AgRP ...

Novo Nordisk said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6, when combined with ...

Briggs argues that governments must adopt wide ranging strategies and policies to tackle unhealthy food and obesity.1 Another of the “key commercial drivers of poor diet and ill health” is a lack of ...

Overweight and obesity means weighing more than what is thought to be healthy for a person of that height. Body mass index (BMI), which estimates your level of body fat based on your height and weight ...